CORONARY INTERVENTIONS

Second-generation magnesium scaffold Magmaris: device design and preclinical evaluation in a porcine coronary artery model

EuroIntervention 2017;13:440-449 published online March 2017. DOI: 10.4244/EIJ-D-16-00915

Ron Waksman1*, MD; Philine Zumstein2, BSBT; Martin Pritsch2, DipBI; Eric Wittchow3, PhD; Michael Haude4, MD; Capucine Lapointe-Corriveau5, MSc; Guy Leclerc5, MD; Michael Joner6, MD

1. MedStar Washington Hospital Center, Washington, DC, USA; 2. Biotronik AG, Bülach, Switzerland; 3. CVPath Institute, Inc, Gaithersburg, MD, USA; 4. Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss, Germany;5. AccelLAB Inc., Boisbriand, QC, Canada

Aims: The second-generation drug-eluting absorbable magnesium scaffold Magmaris, recently introduced for the treatment of obstructive coronary atherosclerotic lesions, suggests a good saf

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

bioresorbable scaffoldsclinical researchoptical coherence tomography

Coronary interventionsStents and scaffolds

Share on Facebook Share on Twitter Share on Linkedin